Your browser is no longer supported. Please, upgrade your browser.
KBLM KBL Merger Corp. IV monthly Stock Chart
KBL Merger Corp. IV
Index- P/E224.04 EPS (ttm)0.05 Insider Own33.36% Shs Outstand8.17M Perf Week3.24%
Market Cap86.01M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month0.06%
Income- PEG- EPS next Q- Inst Own87.09% Short Float- Perf Quarter0.67%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.02 Perf Half Y4.26%
Book/sh1.16 P/B9.05 EPS next Y- ROA- Target Price- Perf Year8.22%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.17 - 10.59 Perf YTD3.24%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-0.57% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low14.83% ATR0.11
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)51.64 Volatility0.36% 0.94%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.00 Prev Close10.53
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume66.34K Price10.53
Recom- SMA200.14% SMA500.31% SMA2002.98% Volume0 Change0.00%
Jul-28-19 04:36PM  KBL Merger Corp Acquires Cannabis-Focused Biotech Company Benzinga
Jul-26-19 09:00AM  KBL Merger Corp. IV SPAC Signs Definitive Business Combination Agreement to Acquire CannBioRx Life Sciences Corp. PR Newswire
May-15-19 09:05AM  Cannabis Stock News Daily Roundup May 15 Market Exclusive
May-14-19 08:00AM  KBL Merger Corp. IV SPAC Announces Non-Binding Term Sheet to Acquire CannBioRx Life Sciences Corp. and its Three Interactive Programs PR Newswire
KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.